Following Germany’s news that it will start offering Covid booster shots from September, the pharmaceutical companies responsible for delivering them are set to generate an income high enough to rival the US flu vaccine market, reported Reuters. Agreements to supply the initial two doses of their vaccines are set to be bolstered by the third jab. A booster shot will also be offered to anyone who received the two-dose AstraZeneca or single-dose Johnson & Johnson vaccines “in the interests of preventative healthcare”, according to a document released by Germany’s health minister Jens Spahn. Both AstraZeneca and Johnson & Johnson are viral vector vaccines, which teaches the body how to make copies of the spike proteins found in Covid-19. READ ALSO: Covid vaccine mix-and-match: Why is it so common in Germany – and is it safe?

Source: The Local August 14, 2021 14:37 UTC